Australia and New Zealand Surgical and Respiratory Mask Market, By Product Type (Respiratory Mask (Disposable Respiratory Mask, and Reusable Respiratory Mask), Surgical Mask (Disposable Surgical Mask, and Reusable Surgical Mask)), By Sales Channel (Offline and Online)-

Published In : Jun 2023

Code : CMI3720

Pages :131

Formats :

Excel and PDF

Industry : Medical Devices

Market News

Australia & New Zealand Surgical and respiratory Mask Market: Key Developments

In May 2020, First Graphene, the global producer of advanced graphene products, and planarTECH Ltd, a global producer of graphene process equipment and graphene-enabled products, agreed to collaborate on graphene-enhanced personal protective equipment (PPE) products.

In December 2021, EBOS Group Limited (EBOS), the marketer, wholesaler, and distributor of medical, and pharmaceutical products in Australia through its wholly-owned subsidiary EBOS Medical Devices Australia Pty Limited, acquired Australian Pacific Health Supplies TopCo1 Pty Limited and its subsidiaries. EBOS is an ASX (Australian Securities Exchange) and NZX (New Zealand Exchange). Pacific Health Group comprises interests in two businesses that have a presence in Australia, being LifeHealthcare and Australian Biotechnologies, and is a manufacturer and distributor of allografts and distributor of medical devices.

In June 2020, EBOS Group Limited, the marketer, wholesaler, and distributor of medical, and pharmaceutical products in Australia, announced that a mutually beneficial outcome with the Federal Government has been achieved following the recent execution of the 7th Community Pharmacy Agreement. EBOS national healthcare wholesaler and wholly-owned subsidiary Symbion, together with members of the National Pharmaceutical Services Association (NPSA), a part of Australia’s complex health infrastructure has been actively engaged in negotiations with the Department of Health and Federal Minister for Health.

In November 2022, according to the Australian Government Department of Health and Aged Care, the Australian guidelines for the prevention and control of infection in healthcare (the guidelines) described the best way to prevent and reduce infections occurring in healthcare settings including resistant infections. The guidelines include how to manage common infectious agents, for example, gastrointestinal viruses, and evolving infectious agents, for example, influenza or multi-drug resistant organisms.